Transparency

Karyopharm Therapeutics Selects MediSpend's Transparency Solution

Retrieved on: 
Tuesday, October 20, 2020

PORTSMOUTH, N.H., Oct. 20, 2020 /PRNewswire/ --MediSpend announced that Karyopharm Therapeutics(NASDAQ:KPTI) selected MediSpend Transparency Solution to comply with state and federal transparency reporting regulations.

Key Points: 
  • PORTSMOUTH, N.H., Oct. 20, 2020 /PRNewswire/ --MediSpend announced that Karyopharm Therapeutics(NASDAQ:KPTI) selected MediSpend Transparency Solution to comply with state and federal transparency reporting regulations.
  • MediSpend Transparency Solution is a SaaS-based solution that collects, remediates, validates, analyzes and reports transfers of value to comply with state, federal and global transparency laws and codes.
  • Karyopharm Therapeuticswas implemented and went live with MediSpend's Transparency Solution in October 2020.
  • WithMediSpend's best-in-class Transparency Solution, Karyopharm Therapeutics will be able to efficiently and effectively manage continually evolving transparency reporting requirements.

Winners of Second Annual U.S. Transparency Awards Announced

Retrieved on: 
Tuesday, October 20, 2020

Labrador , a global communication firm specializing in regulated disclosure documents, today announces the winners of the second annual U.S. Transparency Awards .

Key Points: 
  • Labrador , a global communication firm specializing in regulated disclosure documents, today announces the winners of the second annual U.S. Transparency Awards .
  • The 2020 U.S. Transparency Awards Best Overall is awarded to The Allstate Corporation for its corporate disclosure across its annual proxy statement, form 10-K, investor relations website and code of conduct.
  • After successfully launching the first U.S. Transparency Awards in 2019, the awards program continues to recognize the quality and completeness of information that top U.S. companies make available to investors.
  • Each year the Transparency Awards criteria evolve and become more specific as the needs of the investor community grow.

Bay Area Women Pioneer a New, Results-Based Donation Model with $4.5+ Million in Donations Focused on Economic Mobility

Retrieved on: 
Monday, October 19, 2020

Twenty-three women philanthropists came together to pioneer this new funding model in the Bay Area.

Key Points: 
  • Twenty-three women philanthropists came together to pioneer this new funding model in the Bay Area.
  • NPXs DIF model is disrupting the status quo by injecting unprecedented accountability and transparency around results to drive real change.
  • The DIF model is easily replicable and could be deployed in every state in America where donors want to drive results.
  • The Bay Area DIF has the potential to drive upward economic mobility for over 800 people in the Bay Area.

clean.io Partners with Index Exchange to Expand Malvertising Protection for Publishers & Consumers

Retrieved on: 
Thursday, October 15, 2020

As Index Exchange continues to scale its omnichannel capabilities, it's become increasingly important to stay several steps ahead of bad actors in the programmatic ecosystem.

Key Points: 
  • As Index Exchange continues to scale its omnichannel capabilities, it's become increasingly important to stay several steps ahead of bad actors in the programmatic ecosystem.
  • "Our technology offers early adopters of anti-malware technology like Index Exchange an additional layer of protection for both their publishers and buyers in order to maintain an open-yet-safe programmatic ecosystem."
  • The integration with clean.io ultimately advances Index Exchange's ability to deliver the cleanest demand possible for publishers.
  • Built on the pillars of neutrality, openness, and the most reliable technology, Index is the ad exchange that media companies trust.

Beyond Compliance: The Ethical and Business Demands for Clinical Trial Transparency, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, October 12, 2020

However, regulatory and corporate obligations also call for disclosure of clinical trial information.

Key Points: 
  • However, regulatory and corporate obligations also call for disclosure of clinical trial information.
  • This provides clinical trial sponsors the opportunity to make transparency a priority and improve the reputation of their brands and the industry as a whole.
  • By repurposing clinical trial information instead of letting it languish in a database, sponsors can turn "patient engagement" from a buzzword to an actionable business practice.
  • For more information or to register for this event, visit Beyond Compliance: The Ethical and Business Demands for Clinical Trial Transparency.

Grand Prix de la Transparence 2020: ESI Group Rewarded for the Transparency of Its Financial and Regulatory Communication

Retrieved on: 
Wednesday, October 7, 2020

This award emphasizes on the daily measures deployed by the Group in favor of an even more reliable, readable and transparent communication, a vector of the companys sustainable development.

Key Points: 
  • This award emphasizes on the daily measures deployed by the Group in favor of an even more reliable, readable and transparent communication, a vector of the companys sustainable development.
  • Corinne Romefort-Rgnier, Corporate Governance Director of ESI Group, comments: We are honored to be rewarded for this new edition of the Grands Prix de la Transparence.
  • This distinction shows the strong and daily commitment of ESI Group's teams to guarantee the transparency of our financial and regulatory communication.
  • Founded in 1973, ESI Group is a leading innovator in Virtual Prototyping solutions and a global enabler of industrial transformation.

CBL Markets Announces First Trades of the Global Emissions Offset™ Contract

Retrieved on: 
Monday, October 5, 2020

NEW YORKand SAN FRANCISCOand SYDNEY, Oct. 5, 2020 /PRNewswire/ -- XCHG , the global marketplace for Intelligent Commodities, today announced the first trades of the Global Emissions Offset (GEO) on XCHG subsidiary CBL Markets .

Key Points: 
  • NEW YORKand SAN FRANCISCOand SYDNEY, Oct. 5, 2020 /PRNewswire/ -- XCHG , the global marketplace for Intelligent Commodities, today announced the first trades of the Global Emissions Offset (GEO) on XCHG subsidiary CBL Markets .
  • The contract standardizes and streamlines the purchasing of offsets, making it simpler to sort through a complex range of options.
  • These initial transactions signify market acceptance of the GEO contract as a benchmark that brings scale, transparency, and liquidity to voluntary offset markets worldwide.
  • "GEO pricing is set by trades on CBL Markets, which reflect the real costs of abating emissions," said Ben Stuart, XCHG Chief Commercial Officer.

CBL Markets Announces First Trades of the Global Emissions Offset™ Contract

Retrieved on: 
Monday, October 5, 2020

NEW YORKand SAN FRANCISCOand SYDNEY, Oct. 5, 2020 /PRNewswire/ -- XCHG , the global marketplace for Intelligent Commodities, today announced the first trades of the Global Emissions Offset (GEO) on XCHG subsidiary CBL Markets .

Key Points: 
  • NEW YORKand SAN FRANCISCOand SYDNEY, Oct. 5, 2020 /PRNewswire/ -- XCHG , the global marketplace for Intelligent Commodities, today announced the first trades of the Global Emissions Offset (GEO) on XCHG subsidiary CBL Markets .
  • The contract standardizes and streamlines the purchasing of offsets, making it simpler to sort through a complex range of options.
  • These initial transactions signify market acceptance of the GEO contract as a benchmark that brings scale, transparency, and liquidity to voluntary offset markets worldwide.
  • "GEO pricing is set by trades on CBL Markets, which reflect the real costs of abating emissions," said Ben Stuart, XCHG Chief Commercial Officer.

TrialScope Adds Eisai to Its Community of Study Sponsors

Retrieved on: 
Thursday, October 1, 2020

Eisai Inc. will manage its global clinical trial disclosure compliance process for upwards of 800 studies using the TrialScope Disclose platform.

Key Points: 
  • Eisai Inc. will manage its global clinical trial disclosure compliance process for upwards of 800 studies using the TrialScope Disclose platform.
  • TrialScope customers include 16 of the top 20 industry sponsors, who rely on its technology for trial disclosure management, patient engagement and study recruitment.
  • "Clinical trial disclosure regulatory compliance is important to Eisai, and not just because it is mandated legally," said Neil Yolland, Director, Global Clinical Trial Transparency and Clinical & Business Systems at Eisai.
  • "We welcome Eisai to the TrialScope community and admire its commitment to global clinical trial disclosure and transparency," said TrialScope CEO Jeff Kozloff.

ADVISORY: Citizens for Transparency and Inclusion PAC to Run TV Ad Slamming DE Governor Carney Immediately Following First Presidential Debate

Retrieved on: 
Tuesday, September 29, 2020

Today, the Delaware-based Political Action Committee, Citizens for Transparency and Inclusion (CTI), announced it would be airing a television ad immediately following tonights Presidential debate on NBC in the Delaware County market area, which includes Wilmington and Dover.

Key Points: 
  • Today, the Delaware-based Political Action Committee, Citizens for Transparency and Inclusion (CTI), announced it would be airing a television ad immediately following tonights Presidential debate on NBC in the Delaware County market area, which includes Wilmington and Dover.
  • Why have 9 Delawareans been shot and killed by police officers with impunity during Governor Carneys time in office?
  • Why did Governor Carney return the Chancery Court to its all white status again?
  • Citizens for Transparency and Inclusion is a Political Action Committee that promotes transparency, accountability, diversity, and inclusion in Delaware's state government and court system.